The Abigail Wexner Research Institute at Nationwide Children, Dublin , United States

Lindsay Alfano is an assistant professor in The Abigail Wexner Research Institute at Nationwide Children’s Hospital. She is a physical therapist specializing in outcome measure administration, selection, and development for patients with neuromuscular diseases.

Center for Research in Myology, Paris , France

Valérie Allamand holds a PhD in human genetics and has been working on muscular dystrophies for almost 3 decades. She supervises a research group within the team led by Gisèle Bonne. Her research focuses on several forms of neuromuscular disorders, including COL6- and LAMA2-RD.

Neurology Rare Disease Center , Coppell , United States

The University of Hong Kong, Hong Kong SAR , China

https://www.worldmusclesociety.org/news/view/meet-the-members-dr-sophelia-chan

Nationwide Childrens Hospital, Columbus , United States

I am a pediatric cardiologist at Nationwide Children's Hospital in Columbus, Ohio who has been working in the field of neuromuscular disease for over 20 years. As we all know the heart is a muscle and an important muscle too!!

Academic Medical Center, Amsterdam , Netherlands

Hospital for Sick Children, Toronto , Canada

Jim Dowling is a pediatric neurologist and senior scientist at the Hospital for Sick Children in Toronto, Canada. His research is focused on gene discovery and therapy development for congenital myopathies.

Stanford university , Mountain View , United States

Newgiza University School of Medicine, Cairo , Egypt

I received my training & my Doctorate degree thesis on the genetics of Neuromuscular disorders in National Institute of Neuroscience NCNP, Japan under the mentorship of Prof. Ikuya Nonaka. Currently I’m the chair & Founder of Myocare National foundation, NGO working with LGMD patients. Also I’m Neurology Department lead & assistant professor of neuromuscular disorders at New Giza University, School of medicine. Also served as the editor for the WMS website section “Myology across the world” since 2020. I'm interested in studying patterns of LGMD patients in the region. I worked as a fellow researcher in NCNP in Tokyo, and completed my Doctorate degree thesis on the genetics of muscular dystrophy. Currently I’m Chair I serve as scientific committee member on the “Egyptian National Genome” project and represent North Africa in the WHO rare disorders panel of experts.

Sorbonne Université, GHU Pitié-Salpêtrière Hospital, AP-HP, Paris, France, Paris , France

Dr Teresinha Evangelista is a Board-certified neurologist and neuropathologist with long standing clinical and research expertise in neuromuscular disorders. Dr Teresinha Evangelista was the president of the Portuguese Society for the Study of Neuromuscular Diseases from 2009 to 2013. In 2018, she became the coordinator of the European Reference Network for rare neuromuscular diseases EURO-NMD. In 2018, she joined the « Unité de Morphologie Neuromusculaire; Institut de Myologie - Sorbonne Université, GHU Pitié-Salpêtrière ».

Nationwide Children's Research Institute, Columbus , United States

Nationwide Children's Hospital, Columbus , United States

0

Charité - Universitätsmedizin Berlin, Berlin , Germany

Felix is a neurologist based in Berlin, Germany, with a focus on hereditary and acquired myopathies. As a member of the LGBTQIA+ community, Felix is dedicated to fostering inclusivity and amplifying the visibility of diverse voices within the World Muscle Society and the broader field of neuromuscular medicine.

Stichting SpierKracht\LGMD CAB, Bilthoven , Netherlands

2006 As mom of two kids with LGMD we founded Stichting SpierKracht. In 10 years we are now serving families worldwide and provide them with all information they need (diagnose, living, education, trials, access). In 2019 we started the LGMD CAB in 2022 I became member of the taskforce DITA

Mayo Clinic, Rochester , United States

I am a Professor of Neurology at Mayo Clinic-Rochester with a special interest in muscle diseases and muscle pathology. My recent research interest has been focusing on: 1) epidemiology and natural history of inclusion body myositis and immune-mediated necrotizing myopathy, 2) amyloid myopathy with and without systemic amyloidosis, 3) sarcoid myopathy and other granulomatous myopathies, 4) immune checkpoint inhibitor-associated myopathy and 5) immune-mediated rippling muscle disease.

Nationwide Children's Hospital, Columbus , United States

Bangalore Baptist Hospital, Bangalore , India

Clinical paediatrics

The University of California, Irvine, Orange , United States

Dr. Tahseen Mozaffar is a Professor of Neurology and Pathology and Laboratory Medicine and the Director of the Division of Neuromuscular Disorders. Dr. Mozaffar serves as chair of one of the biomedical committees and is the Associate Director for the Center for Translational Sciences Award (CTSA) at University of California, Irvine. He is the Principal Investigator for UCI-NEXT, the NeuroNEXT award to the University of California, Irvine, one of 25 such NeuroNEXT sites funded by the NINDS/NIH. He is also the Lead Investigator for a multicenter NIH/NIAMS funded Natural History Study in sIBM (INSPIRE-IBM), which started April 2021. He graduated medical school at the Aga Khan University in Karachi, Pakistan in 1989 and trained in Neurology and Neuromuscular Disorders at Washington University/Barnes Hospital in St. Louis, MO. Dr. Mozaffar has been at UC Irvine since 2000 where he has built an internationally recognized clinical and research program in Neuromuscular Disorders. He is actively involved in clinical and translational research in Neuromuscular Disorders, including currently serving as Principal Site Investigator on over a dozen clinical trials in myasthenia gravis, rare and ultra-rare myopathies and in immune myopathies. He has co-authored over 190 peer-reviewed publications and has authored or co-authored over a dozen book chapters and invited reviews. As an expert in these rare and ultra-rare myopathies, he is actively sought as an advisor by pharmaceutical companies for trial design and identifying disease targets. He is the Director of the nationally recognized Annual UC Irvine Neuromuscular Colloquium, now in its 10th year of existence and Director of the Annual Neuromuscular Pathology Colloquium, now in its 5th year.

UCL GOS Institute of Child Health, London , United Kingdom

Université Libre de Bruxelles - Hôpital Erasme, Brussels , Belgium

Newcastle University , Newcastle upon Tyne , United Kingdom

Volker was trained as a paediatric neurologist at the universities of Düsseldorf and Essen. He wrote his PhD thesis on Duchenne muscular dystrophy and worked as a postdoctoral research fellow at the University of Iowa/USA. He has a long-standing interest in mechanisms of genetic muscle diseases, with research using cell and animal models. His current research also involves the application of muscle imaging and next generation sequencing. He is a principal investigator for a number of natural history and interventional trials, the director of the John Walton Muscular Dystrophy Research Centre and deputy dean of Newcastle University’s Translational and Clinical Research Institute. He is an author on >450 peer-reviewed publications.

Dalhousie University, Halifax , Canada

Cincinnati Children's Hospital, Cincinnati , United States

I am a board-certified pediatric neurologist specialized in neuromuscular disease. I am currently Associate Professor and Attending physician at Cincinnati Children's Hospital Medical Center. I am leading the multidisciplinary comprehensive neuromuscular care program as co-director and neurology lead of the program, also as clinical director of certified Duchenne Muscular Dystrophy care clinic and clinical director of Muscular Dystrophy Association clinic. I am a clinical researcher participating in clinical trials and studies in pediatric neuromuscular diseases.